Healthspan Capital was founded in 2021 by Sebastian Brunemeier, Nathan Cheng, and Michael Chinen. Our fund was the first publicly accessible longevity venture fund listed on Angel List.
Frequently Asked Questions.
We invest in early stage longevity biotech ("LongBio") -- meaning companies that are developing therapeutics that target aging.
We invest in pre-Seed to Series A companies.
Healthspan Capital's investment fund is structured as an AngelList rolling fund. This means we raise capital from investors through subscriptions on a quarterly basis and can deploy capital immediately to invest in promising founders and startups. Any capital that is not deployed in a quarter is "rolled over" into the next.
Investors can increase, decrease, or cancel their investment subscription as they like, making this rolling fund structure flexible for investors.
For more information on rolling fund structures please see this article.
The minimum investment amount is $5,000 USD.
20% carry, 2% management fee.